Dr. Nazira El-Hage's research lab focuses on understanding how certain medications used for HIV prevention, like cabotegravir, interact with opioids, such as morphine and naltrexone, particularly in individuals with opioid use disorders. The lab investigates how these drug interactions may affect drug metabolism, toxicity, and effectiveness, especially using animal models. Their work aims to provide insights that could improve treatment strategies for patients who are dealing with both HIV and opioid dependence.

Dr. Hoshang Unwalla's lab focuses on understanding how HIV affects the lungs, particularly in people living with HIV who develop COPD. The team explores the role of microRNAs and the lung's molecular clock in this process, aiming to find new ways to prevent and treat COPD in these individuals. Their work combines cutting-edge techniques, like CRISPR, to manipulate gene expression and address the unique challenges posed by HIV in lung health.